Berberis aristata Boosts Platelet Count in Heparin-Induced Thrombocytopenia Model
DOI:
https://doi.org/10.37285/ijpsn.2024.17.4.7Abstract
Background and purpose of the study: This study investigated the effectiveness of Berberis aristata, a medicinal plant commonly used in Ayurvedic medicine, in increasing platelet count in a heparin-induced thrombocytopenia model in rats.
Research rationale: Conditions like dengue fever, and certain immunological disorders result in thrombocytopenia. No standard treatment for such conditions is available. The only way of treatment is to increase platelet count naturally with alternative medicines. Therefore, well well-known medicinal plant Berberis aristata and its main constituent berberine are tested for platelet-enhancing potential in this study.
Method: Dried stem powder of Berberis aristata was extracted by using methanol and HCl (2:3, v/v) by Soxhlet extractor at 45-50 0C. The crude extract was used to obtain an alkaloidal fraction. Both the crude extract and the alkaloidal fraction were analysed by developing TLC using n-butanol: glacial acetic acid: water (7:2:1, v/v/v) as a solvent system. Platelet-enhancing potential screening was done by administering the crude extract, alkaloidal fraction as well as berberine in rats with heparin-induced thrombocytopenia. Statistical analysis was applied.
Result: The results showed that increase in platelet count in Berberis aristata extract, alkaloidal fraction, and berberine-treated groups as compared to the control group.
Conclusion: All the test groups showed significant platelet-enhancing activity in comparison to the control group. Among the entire test groups, the extract of Berberis aristata was found to have the most significant platelet-enhancing potential.
Downloads
Metrics
Keywords:
Berberis aristata, Berberine, Platelet, Thrombocytopenia, Alkaloidal Fraction, Platelet countPublished
How to Cite
Issue
Section
References
Wasana K, Attanayake A, Weerarathna K. Natural drug leads as novel DPP-IV inhibitors targeting the management of type 2 diabetes mellitus. J Complement Med Res. 2020;11(1):43.
Upadhyay, T. K., Das, S., Mathur, M., Alam, M., Bhardwaj, R., Joshi, N., & Sharangi, A. B. (2024). Medicinal plants and their bioactive components with antidiabetic potentials. Antidiabetic Medicinal Plants, 327-364.
Acharya, C. K., Das, B., Madhu, N. R., Sau, S., De, M., & Sarkar, B. (2023). A Comprehensive Pharmacological Appraisal of Indian Traditional Medicinal Plants with Anti-diabetic Potential. In Advances in Diabetes Research and Management (pp. 163-193). Singapore: Springer Nature Singapore.
Sati SC, Joshi S. Aspects of Antifungal Potential of Ethnobotanically Known Medicinal Plants. Research Journal of Medicinal Plants. 2011;5(4): 377- 391.
Patel J, Aneja K, Tiwari R. A review on bioavailability and bioequivalence trials and its necessity. Int J Pharmacy Pharm Sci. 2010;2(3):1-8.
Jain, S., Tripathi, S., & Tripathi, P. K. (2023). Antioxidant and antiarthritic potential of berberine: In vitro and in vivo studies. Chinese herbal medicines, 15(4), 549–555. https://doi.org/10.1016/j.chmed.2023.02.007.
Shailasree S, Ruma K, Kini KR, Niranjana SR, Prakash HS. Potential anti-inflammatory bioactives from medicinal plants of Western Ghats, India. Pharmacogn Commun. 2012;2(2):71-7.
Mazumder PM, Das S, Das S, Das MK. Cytotoxic activity of methanolic extracts of Berberis aristata DC and Hemidesmus indicus R. Br. MCF7 cell line. J Curr Pharm Res. 2010;1:12-5.
Joshi PV, Shirkhedkar AA, Prakash K, Maheshwari VL. Antidiarrheal activity, chemical and toxicity profile of Berberis aristata. Pharmaceutical Biology. 2011 Jan;49(1):94-100.
Gilani AH, Janbaz KH, Aziz N, Herzig MJ, Kazmi MM, Choudhary M, et al. Possible mechanism of selective inotropic activity of the n-butanolic fraction from Berberis aristata fruit. General Pharmacology: The Vascular System. 1999 Nov;33(5):407-14.
Razzaq FA, Khan RA, Feroz Z, Afroz S. Effect of Berberis aristata on lipid profile and coagulation parameters. Afr. J. Pharm. Pharmacol. 2011;5(7):943-7.
Shrivastav, A., Mishra, A. K., & Gupta, A. K. (2023). Evaluation of Wound Healing Potential of Root Bark Extract of Berberis aristata and Molecular Docking Analysis of Berberis Phytoconstituents. Current Drug Discovery Technologies, 20(3), 21-37.
Gasmi, A., Asghar, F., Zafar, S., Oliinyk, P., Khavrona, O., Lysiuk, R., ... & Bjørklund, G. (2024). Berberine: Pharmacological features in health, disease and aging. Current Medicinal Chemistry, 31(10), 1214-1234.
Lamichhane B, Adhikari S, Shrestha P, Govinda Shrestha B. Study of phytochemical, antioxidant, antimicrobial and anticancer activity of Berberis Aristata. JTLS. 2014 Jan 1;4(1):01-7.
Das S, Das MK, Mazumder PM, Das S, Basu SP. Cytotoxic Activity of Methanolic Extract of Berberis aristata DC on Colon Cancer. Global J. Pharmacol. 2009;3(3):137-140.
Sharmila KJ, Monisha SM, Beevi AA, Deebarathi V. Antibacterial, antioxidant, anticancer effects and GCMS analysis of Berberis aristata. Biomedicine. 2020 Nov 9;40(3):286-93.
Pai KS, Srilatha P, Suryakant K, Setty MM, Nayak PG, Rao CM, Baliga MS. Anticancer activity of Berberis aristata in Ehrlich ascites carcinoma-bearing mice: a preliminary study. Pharmaceutical biology. 2012 Mar 1;50(3):270-7.
Anis KV, Rajeshkumar NV, Kuttan R. Inhibition of chemical carcinogenesis by berberine in rats and mice. Journal of Pharmacy and Pharmacology. 2001 May;53(5):763-8.
Rauf A, Abu-Izneid T, Khalil AA, Imran M, Shah ZA, Emran TB, Mitra S, Khan Z, Alhumaydhi FA, Aljohani AS, Khan I. Berberine as a potential anticancer agent: A comprehensive review. Molecules. 2021 Dec 4;26(23):7368.
Devarajan N, Jayaraman S, Mahendra J, Venkatratnam P, Rajagopal P, Palaniappan H, et al. Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies. Phytotherapy Research. 2021 Jun;35(6):3059-77.
Arya R, Singh DC, Tiwari RC, Tripathi BM. An overview of ethanomedicine and future aspects of ethanomedicinal plants. International Journal of Ayurveda and pharmacy research. 2016;4:29-33.
Provan D, Semple JW. Recent advances in the mechanisms and treatment of immune thrombocytopenia. eBioMedicine. 2022 Feb;76:103820.
The Ayurvedic Pharmacopoeia of India, Part I, Volume II, First Edition, Government of India, Ministry of Health and Family Welfare, Department of Indian systems of Medicine and Homoeopathy, pp 33-34.
Patel MB, Mishra S. Hypoglycemic activity of alkaloidal fraction of Tinospora cordifolia. Phytomedicine. 2011 Sep 15;18(12):1045-52.
Khandelwal KR and Sethi V (2008), Practical Pharmacognosy Techniques and Experiments, 27th Edition: 25.1-25.9.
Cahyati WH, Siyam N, Putriningtyas ND. The potential of red dragon fruit peel yogurt to improve platelet levels in heparin-induced thrombocytopenia in Wistar rats. Potr S J F Sci. 2021 Mar 28;15:218-25.
